---
title: "Bingham Healthcare increases grant success with Euna Grants, securing $700,000/year, growing to 16+ applications/year."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273835661.md"
description: "In Atlanta and Toronto, Euna Solutions®, a prominent provider of specialized cloud solutions for the public sector, is marking the achievement of Bingham Healthcare in southeastern Idaho. By utilizing Euna Grants, a cloud platform, Bingham Healthcare, a nonprofit health system, has significantly enhanced its grant capabilities. The organization has escalated its active grant applications from five to over sixteen yearly. Consequently, they now consistently secure individual awards annually."
datetime: "2026-01-27T11:12:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273835661.md)
  - [en](https://longbridge.com/en/news/273835661.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273835661.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/273835661.md) | [繁體中文](https://longbridge.com/zh-HK/news/273835661.md)


# Bingham Healthcare increases grant success with Euna Grants, securing $700,000/year, growing to 16+ applications/year.

In Atlanta and Toronto, Euna Solutions®, a prominent provider of specialized cloud solutions for the public sector, is marking the achievement of Bingham Healthcare in southeastern Idaho. By utilizing Euna Grants, a cloud platform, Bingham Healthcare, a nonprofit health system, has significantly enhanced its grant capabilities. The organization has escalated its active grant applications from five to over sixteen yearly. Consequently, they now consistently secure individual awards annually.

### Related Stocks

- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [Tianhong CNI BIOMEDICINE ETF (159859.CN)](https://longbridge.com/en/quote/159859.CN.md)
- [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/en/quote/512290.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/en/quote/159837.CN.md)
- [Direxion Daily S&P Biotech Bull 3X ETF (LABU.US)](https://longbridge.com/en/quote/LABU.US.md)
- [Ping An CSI Medicine and Medical Device Innovation ETF (516820.CN)](https://longbridge.com/en/quote/516820.CN.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/en/quote/159849.CN.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/en/quote/516930.CN.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)
- [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md)
- [ProShares UltraShort Nasdaq Biotech (BIS.US)](https://longbridge.com/en/quote/BIS.US.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/en/quote/516500.CN.md)
- [Founder Fubon CSI Medicine and Medical Device Innovation ETF (560600.CN)](https://longbridge.com/en/quote/560600.CN.md)
- [Huaan Hang Seng Biotech ETF (159102.CN)](https://longbridge.com/en/quote/159102.CN.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Canada's Perimeter Medical Imaging prelim Q4 revenue jumps 143%](https://longbridge.com/en/news/281240360.md)
- [Stocks in Play: Ventripoint Diagnostics Ltd](https://longbridge.com/en/news/281544776.md)
- [Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat](https://longbridge.com/en/news/281233412.md)
- [Barclays Sticks to Its Buy Rating for UCB SA (0NZT)](https://longbridge.com/en/news/280966907.md)
- [BUZZ-Caribou rises on FDA's regenerative medicine advanced therapy tag for blood cancer therapy](https://longbridge.com/en/news/281186075.md)